ArticleJournal of gastroenterology2022

Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.

Hidemasa Kawabata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.